Osteoprotegerin deficiency and juvenile Paget's disease

被引:298
作者
Whyte, MP
Obrecht, SE
Finnegan, PM
Jones, JL
Podgornik, MN
McAlister, WH
Mumm, S
机构
[1] Shriners Hosp Children, Ctr Metab Bone Dis & Mol Res, St Louis, MO 63131 USA
[2] Washington Univ, Sch Med, Barnes Jewish Hosp, Div Bone & Mineral Dis, St Louis, MO USA
[3] Washington Univ, Sch Med, Edward Mallinckrodt Inst Radiol, St Louis Childrens Hosp, St Louis, MO 63110 USA
关键词
D O I
10.1056/NEJMoa013096
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Background Juvenile Paget's disease, an autosomal recessive osteopathy, is characterized by rapidly remodeling woven bone, osteopenia, fractures, and progressive skeletal deformity. The molecular basis is not known. Osteoprotegerin deficiency could explain juvenile Paget's disease because osteoprotegerin suppresses bone turnover by functioning as a decoy receptor for osteoclast differentiation factor (also called RANK ligand). Methods We evaluated two apparently unrelated Navajo patients with juvenile Paget's disease for defects in the gene encoding osteoprotegerin (TNFRSF11B) using polymerase-chain-reaction (PCR) amplification followed by direct sequencing and Southern blotting of genomic DNA. Genetic markers near TNFRSF11B were evaluated by both a PCR method that involved sequence-tagged site-content mapping of a deletion of TNFRSF11B and PCR spanning the DNA break points. Results Both patients had a homozygous deletion of TNFRSF11B, with identical break points, on chromosome 8q24.2. The defect spans approximately 100 kb, but neighboring genes are intact. We found that serum levels of osteoprotegerin and soluble osteoclast differentiation factor were undetectable and markedly increased, respectively. Conclusions Juvenile Paget's disease can result from osteoprotegerin deficiency caused by homozygous deletion of TNFRSF11B.
引用
收藏
页码:175 / 184
页数:10
相关论文
共 35 条
[1]   The effect of a single dose of osteoprotegerin in postmenopausal women [J].
Bekker, PJ ;
Holloway, D ;
Nakanishi, A ;
Arrighi, M ;
Leese, PT ;
Dunstan, CR .
JOURNAL OF BONE AND MINERAL RESEARCH, 2001, 16 (02) :348-360
[2]   osteoprotegerin-deficient mice develop early onset osteoporosis and arterial calcification [J].
Bucay, N ;
Sarosi, I ;
Dunstan, CR ;
Morony, S ;
Tarpley, J ;
Capparelli, C ;
Scully, S ;
Tan, HL ;
Xu, WL ;
Lacey, DL ;
Boyle, WJ ;
Simonet, WS .
GENES & DEVELOPMENT, 1998, 12 (09) :1260-1268
[3]  
*BUR CENS, 1994, 1990 CENS POP HOUS C
[4]  
CAFFEY J, 1972, Bulletin of the Hospital for Joint Diseases, V33, P81
[5]   FAMILIAL IDIOPATHIC HYPERPHOSPHATASIA (FIH) - RESPONSE TO LONG-TERM TREATMENT WITH PAMIDRONATE (APD) [J].
CASSINELLI, HR ;
MAUTALEN, CA ;
HEINRICH, JJ ;
MIGLIETTA, A ;
BERGADA, C .
BONE AND MINERAL, 1992, 19 (02) :175-184
[6]   HYPERCALCIURIA IN CHILDREN SEVERELY AFFECTED WITH OSTEOGENESIS IMPERFECTA [J].
CHINES, A ;
PETERSEN, DJ ;
SCHRANCK, FW ;
WHYTE, MP .
JOURNAL OF PEDIATRICS, 1991, 119 (01) :51-57
[7]  
Cole D.E.C., 1996, STUDIES STOMATOLOGY, P245
[8]   FAMILIAL HYPERPHOSPHATASEMIA - DIAGNOSIS IN EARLY INFANCY AND RESPONSE TO HUMAN THYROCALCITONIN THERAPY [J].
DUNN, V ;
CONDON, VR ;
RALLISON, ML .
AMERICAN JOURNAL OF ROENTGENOLOGY, 1979, 132 (04) :541-545
[9]  
ENG AM, 1975, ARCH DERMATOL, V111, P271
[10]  
GILPIN L, 1968, ENDURING NAVAHO, P255